{
    "id": "wrong_mix_random_starring_00134_3",
    "rank": 65,
    "data": {
        "url": "https://med.uc.edu/depart/intmed/divisions/cardio/directory/entire-directory/Index/Pubs/beckerrc",
        "read_more_link": "",
        "language": "en",
        "title": "Richard C. Becker, MD",
        "top_image": "https://lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "meta_img": "https://lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "images": [
            "https://webcentral.uc.edu/eprof/media/repository/0681BeckerRichard5227.jpg",
            "https://lcdn.uc.edu/uc-assets/images/seals/EProf_seal.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "//lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "meta_site_name": "Default",
        "canonical_link": "https://med.uc.edu/depart/intmed/divisions/cardio/directory/entire-directory",
        "text": "Becker, Richard C 2023. Evaluating chest pain in patients with post COVID conditions permission to think outside of the box. Journal of thrombosis and thrombolysis, 55 4, 592-603\n\nBecker, Richard C; Ortel, Thomas L 2023. Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity? JAMA internal medicine, 183 6, 532-533\n\nDavidsson, Pia; Eketjäll, Susanna; Eriksson, Niclas; Walentinsson, Anna; Becker, Richard C; Cavallin, Anders; Bogstedt, Anna; Collén, Anna; Held, Claes; James, Stefan; Siegbahn, Agneta; Stewart, Ralph; Storey, Robert F; White, Harvey; Wallentin, Lars 2023. Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease. Cardiovascular research, 119 7, 1596-1605\n\nEllison, Corie A; Arnot, Jon A; Felter, Susan P; Daston, George P; Becker, Richard A; Toose, Liisa; Armitage, James M; Sangion, Alessandro; Looky, Alexandra; Brown, Trevor N; Li, Li 2023. Letter to the editor regarding recent publication titled \"Developing an internal threshold of toxicological concern (iTTC)\" by Arnot et al. (2022). Journal of exposure science & environmental epidemiology, ,\n\nHjort, Marcus; Eggers, Kai M; Lakic, Tatevik Ghukasyan; Lindbäck, Johan; Budaj, Andrzej; Cornel, Jan H; Giannitsis, Evangelos; Katus, Hugo A; Siegbahn, Agneta; Storey, Robert F; Becker, Richard C; Wallentin, Lars; Lindahl, Bertil 2023. Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial. Journal of the American Heart Association, 12 1, e027466\n\nRen, Lu; Du, Wa; Song, Dan; Lu, Haocheng; Hamblin, Milton H; Wang, Chenran; Du, Chunying; Fan, Guo-Chang; Becker, Richard C; Fan, Yanbo 2023. Genetic ablation of diabetes-associated gene Ccdc92 reduces obesity and insulin resistance in mice. iScience, 26 1, 105769\n\nSelf, Wesley H; Shotwell, Matthew S; Gibbs, Kevin W; de Wit, Marjolein; Files, D Clark; Harkins, Michelle; Hudock, Kristin M; Merck, Lisa H; Moskowitz, Ari; Apodaca, Krystle D; Barksdale, Aaron; Safdar, Basmah; Javaheri, Ali; Sturek, Jeffrey M; Schrager, Harry; Iovine, Nicole; Tiffany, Brian; Douglas, Ivor S; Levitt, Joseph; Busse, Laurence W; Ginde, Adit A; Brown, Samuel M; Hager, David N; Boyle, Katherine; Duggal, Abhijit; Khan, Akram; Lanspa, Michael; Chen, Peter; Puskarich, Michael; Vonderhaar, Derek; Venkateshaiah, Lokesh; Gentile, Nina; Rosenberg, Yves; Troendle, James; Bistran-Hall, Amanda J; DeClercq, Josh; Lavieri, Robert; Joly, Meghan Morrison; Orr, Michael; Pulley, Jill; Rice, Todd W; Schildcrout, Jonathan S; Semler, Matthew W; Wang, Li; Bernard, Gordon R; Collins, Sean P 2023. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. JAMA, 329 14, 1170-1182\n\nBatra, Gorav; Lindbäck, Johan; Becker, Richard C; Harrington, Robert A; Held, Claes; James, Stefan K; Kempf, Tibor; Lopes, Renato D; Mahaffey, Kenneth W; Steg, Philippe Gabriel; Storey, Robert F; Swahn, Eva; Wollert, Kai C; Siegbahn, Agneta; Wallentin, Lars 2022. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology, 80 18, 1735-1747\n\nBecker, Richard; Görner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. Trichome Transcripts as Efficiency Control for Synthetic Biology and Molecular Farming. Methods in molecular biology (Clifton, N.J.), 2379 , 265-276\n\nEckman, Mark H; Wise, Ruth; Knochelmann, Carol; Mardis, Rachael; Wright, Sharon; Gummadi, Ashish; Dixon, Estrelita; Becker, Richard; Schauer, Daniel P; Flaherty, Matthew L; Costea, Alexandru; Kleindorfer, Dawn; Ireton, Rob; Baker, Pete; Harnett, Brett M; Adejare, Adeboye; Leonard, Anthony C; Sucharew, Heidi; Costanzo, Amy; Arduser, Lora; Kues, John 2022. Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation - Study protocol. American heart journal, 247 , 42-54\n\nGorog, Diana A; Storey, Robert F; Gurbel, Paul A; Tantry, Udaya S; Berger, Jeffrey S; Chan, Mark Y; Duerschmied, Daniel; Smyth, Susan S; Parker, William A E; Ajjan, Ramzi A; Vilahur, Gemma; Badimon, Lina; Berg, Jurrien M Ten; Cate, Hugo Ten; Peyvandi, Flora; Wang, Taia T; Becker, Richard C 2022. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nature reviews. Cardiology, 19 7, 475-495\n\nHaley, Jessica E; Woodly, Shalayna A; Daniels, Stephen R; Falkner, Bonita; Ferguson, Michael A; Flynn, Joseph T; Hanevold, Coral D; Hooper, Stephen R; Ingelfinger, Julie R; Khoury, Philip R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin E; Mitsnefes, Mark; Becker, Richard C; Rosner, Bernard A; Samuels, Joshua; Tran, Andrew H; Urbina, Elaine M 2022. Association of Blood Pressure-Related Increase in Vascular Stiffness on Other Measures of Target Organ Damage in Youth. Hypertension (Dallas, Tex. : 1979), 79 9, 2042-2050\n\nJones, Holly J; Butsch Kovacic, Melinda; Lambert, Joshua; Almallah, Wala'a R; Becker, Richard; de Las Fuentes, Lisa; Bakas, Tamilyn 2022. A randomized feasibility trial of the Midlife Black Women's Stress and Wellness intervention (B-SWELL); a community participatory intervention to increase adoption of Life's Simple 7 healthy lifestyle behaviors. Translational behavioral medicine, 12 11, 1084-1095\n\nNelson, Thomas A; Parker, William A E; Ghukasyan Lakic, Tatevik; Westerbergh, Johan; James, Stefan K; Siegbahn, Agneta; Becker, Richard C; Himmelmann, Anders; Wallentin, Lars; Storey, Robert F 2022. Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy. Platelets, 33 3, 425-431\n\nPrice, Joshua J; Urbina, Elaine M; Carlin, Kristen; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2022. Cardiovascular Risk Factors and Target Organ Damage in Adolescents: The SHIP AHOY Study. Pediatrics, 149 6,\n\nRusyn, Ivan; Sakolish, Courtney; Kato, Yuki; Stephan, Clifford; Vergara, Leoncio; Hewitt, Philip; Bhaskaran, Vasanthi; Davis, Myrtle; Hardwick, Rhiannon; Ferguson, Stephen S; Stanko, Jason P; Bajaj, Piyush; Adkins, Karissa; Sipes, Nisha S; Hunter, Sid; Baltazar, Maria T; Carmichael, Paul L; Sadh, Kritika; Becker, Richard A 2022. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological sciences : an official journal of the Society of Toxicology, ,\n\n, ; Goligher, Ewan C; Bradbury, Charlotte A; McVerry, Bryan J; Lawler, Patrick R; Berger, Jeffrey S; Gong, Michelle N; Carrier, Marc; Reynolds, Harmony R; Kumar, Anand; Turgeon, Alexis F; Kornblith, Lucy Z; Kahn, Susan R; Marshall, John C; Kim, Keri S; Houston, Brett L; Derde, Lennie P G; Cushman, Mary; Tritschler, Tobias; Angus, Derek C; Godoy, Lucas C; McQuilten, Zoe; Kirwan, Bridget-Anne; Farkouh, Michael E; Brooks, Maria M; Lewis, Roger J; Berry, Lindsay R; Lorenzi, Elizabeth; Gordon, Anthony C; Ahuja, Tania; Al-Beidh, Farah; Annane, Djillali; Arabi, Yaseen M; Aryal, Diptesh; Baumann Kreuziger, Lisa; Beane, Abi; Bhimani, Zahra; Bihari, Shailesh; Billett, Henny H; Bond, Lindsay; Bonten, Marc; Brunkhorst, Frank; Buxton, Meredith; Buzgau, Adrian; Castellucci, Lana A; Chekuri, Sweta; Chen, Jen-Ting; Cheng, Allen C; Chkhikvadze, Tamta; Coiffard, Benjamin; Contreras, Aira; Costantini, Todd W; de Brouwer, Sophie; Detry, Michelle A; Duggal, Abhijit; Džavík, Vladimír; Effron, Mark B; Eng, Heather F; Escobedo, Jorge; Estcourt, Lise J; Everett, Brendan M; Fergusson, Dean A; Fitzgerald, Mark; Fowler, Robert A; Froess, Joshua D; Fu, Zhuxuan; Galanaud, Jean P; Galen, Benjamin T; Gandotra, Sheetal; Girard, Timothy D; Goodman, Andrew L; Goossens, Herman; Green, Cameron; Greenstein, Yonatan Y; Gross, Peter L; Haniffa, Rashan; Hegde, Sheila M; Hendrickson, Carolyn M; Higgins, Alisa M; Hindenburg, Alexander A; Hope, Aluko A; Horowitz, James M; Horvat, Christopher M; Huang, David T; Hudock, Kristin; Hunt, Beverley J; Husain, Mansoor; Hyzy, Robert C; Jacobson, Jeffrey R; Jayakumar, Devachandran; Keller, Norma M; Khan, Akram; Kim, Yuri; Kindzelski, Andrei; King, Andrew J; Knudson, M Margaret; Kornblith, Aaron E; Kutcher, Matthew E; Laffan, Michael A; Lamontagne, Francois; Le Gal, Grégoire; Leeper, Christine M; Leifer, Eric S; Lim, George; Gallego Lima, Felipe; Linstrum, Kelsey; Litton, Edward; Lopez-Sendon, Jose; Lother, Sylvain A; Marten, Nicole; Saud Marinez, Andréa; Martinez, Mary; Mateos Garcia, Eduardo; Mavromichalis, Stavroula; McAuley, Daniel F; McDonald, Emily G; McGlothlin, Anna; McGuinness, Shay P; Middeldorp, Saskia; Montgomery, Stephanie K; Mouncey, Paul R; Murthy, Srinivas; Nair, Girish B; Nair, Rahul; Nichol, Alistair D; Nicolau, Jose C; Nunez-Garcia, Brenda; Park, John J; Park, Pauline K; Parke, Rachael L; Parker, Jane C; Parnia, Sam; Paul, Jonathan D; Pompilio, Mauricio; Quigley, John G; Rosenson, Robert S; Rost, Natalia S; Rowan, Kathryn; Santos, Fernanda O; Santos, Marlene; Santos, Mayler O; Satterwhite, Lewis; Saunders, Christina T; Schreiber, Jake; Schutgens, Roger E G; Seymour, Christopher W; Siegal, Deborah M; Silva, Delcio G; Singhal, Aneesh B; Slutsky, Arthur S; Solvason, Dayna; Stanworth, Simon J; Turner, Anne M; van Bentum-Puijk, Wilma; van de Veerdonk, Frank L; van Diepen, Sean; Vazquez-Grande, Gloria; Wahid, Lana; Wareham, Vanessa; Widmer, R Jay; Wilson, Jennifer G; Yuriditsky, Eugene; Zhong, Yongqi; Berry, Scott M; McArthur, Colin J; Neal, Matthew D; Hochman, Judith S; Webb, Steven A; Zarychanski, Ryan 2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England journal of medicine, 385 9, 777-789\n\n, ; Lawler, Patrick R; Goligher, Ewan C; Berger, Jeffrey S; Neal, Matthew D; McVerry, Bryan J; Nicolau, Jose C; Gong, Michelle N; Carrier, Marc; Rosenson, Robert S; Reynolds, Harmony R; Turgeon, Alexis F; Escobedo, Jorge; Huang, David T; Bradbury, Charlotte A; Houston, Brett L; Kornblith, Lucy Z; Kumar, Anand; Kahn, Susan R; Cushman, Mary; McQuilten, Zoe; Slutsky, Arthur S; Kim, Keri S; Gordon, Anthony C; Kirwan, Bridget-Anne; Brooks, Maria M; Higgins, Alisa M; Lewis, Roger J; Lorenzi, Elizabeth; Berry, Scott M; Berry, Lindsay R; Aday, Aaron W; Al-Beidh, Farah; Annane, Djillali; Arabi, Yaseen M; Aryal, Diptesh; Baumann Kreuziger, Lisa; Beane, Abi; Bhimani, Zahra; Bihari, Shailesh; Billett, Henny H; Bond, Lindsay; Bonten, Marc; Brunkhorst, Frank; Buxton, Meredith; Buzgau, Adrian; Castellucci, Lana A; Chekuri, Sweta; Chen, Jen-Ting; Cheng, Allen C; Chkhikvadze, Tamta; Coiffard, Benjamin; Costantini, Todd W; de Brouwer, Sophie; Derde, Lennie P G; Detry, Michelle A; Duggal, Abhijit; Džavík, Vladimír; Effron, Mark B; Estcourt, Lise J; Everett, Brendan M; Fergusson, Dean A; Fitzgerald, Mark; Fowler, Robert A; Galanaud, Jean P; Galen, Benjamin T; Gandotra, Sheetal; García-Madrona, Sebastian; Girard, Timothy D; Godoy, Lucas C; Goodman, Andrew L; Goossens, Herman; Green, Cameron; Greenstein, Yonatan Y; Gross, Peter L; Hamburg, Naomi M; Haniffa, Rashan; Hanna, George; Hanna, Nicholas; Hegde, Sheila M; Hendrickson, Carolyn M; Hite, R Duncan; Hindenburg, Alexander A; Hope, Aluko A; Horowitz, James M; Horvat, Christopher M; Hudock, Kristin; Hunt, Beverley J; Husain, Mansoor; Hyzy, Robert C; Iyer, Vivek N; Jacobson, Jeffrey R; Jayakumar, Devachandran; Keller, Norma M; Khan, Akram; Kim, Yuri; Kindzelski, Andrei L; King, Andrew J; Knudson, M Margaret; Kornblith, Aaron E; Krishnan, Vidya; Kutcher, Matthew E; Laffan, Michael A; Lamontagne, Francois; Le Gal, Grégoire; Leeper, Christine M; Leifer, Eric S; Lim, George; Lima, Felipe Gallego; Linstrum, Kelsey; Litton, Edward; Lopez-Sendon, Jose; Lopez-Sendon Moreno, Jose L; Lother, Sylvain A; Malhotra, Saurabh; Marcos, Miguel; Saud Marinez, Andréa; Marshall, John C; Marten, Nicole; Matthay, Michael A; McAuley, Daniel F; McDonald, Emily G; McGlothlin, Anna; McGuinness, Shay P; Middeldorp, Saskia; Montgomery, Stephanie K; Moore, Steven C; Morillo Guerrero, Raquel; Mouncey, Paul R; Murthy, Srinivas; Nair, Girish B; Nair, Rahul; Nichol, Alistair D; Nunez-Garcia, Brenda; Pandey, Ambarish; Park, Pauline K; Parke, Rachael L; Parker, Jane C; Parnia, Sam; Paul, Jonathan D; Pérez González, Yessica S; Pompilio, Mauricio; Prekker, Matthew E; Quigley, John G; Rost, Natalia S; Rowan, Kathryn; Santos, Fernanda O; Santos, Marlene; Olombrada Santos, Mayler; Satterwhite, Lewis; Saunders, Christina T; Schutgens, Roger E G; Seymour, Christopher W; Siegal, Deborah M; Silva, Delcio G; Shankar-Hari, Manu; Sheehan, John P; Singhal, Aneesh B; Solvason, Dayna; Stanworth, Simon J; Tritschler, Tobias; Turner, Anne M; van Bentum-Puijk, Wilma; van de Veerdonk, Frank L; van Diepen, Sean; Vazquez-Grande, Gloria; Wahid, Lana; Wareham, Vanessa; Wells, Bryan J; Widmer, R Jay; Wilson, Jennifer G; Yuriditsky, Eugene; Zampieri, Fernando G; Angus, Derek C; McArthur, Colin J; Webb, Steven A; Farkouh, Michael E; Hochman, Judith S; Zarychanski, Ryan 2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England journal of medicine, 385 9, 790-802\n\nBazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. Cells, 10 2,\n\nBazrafshan, Sholeh; Sibilia, Robert; Girgla, Saavia; Viswanathan, Shiv Kumar; Puckelwartz, Megan J; Sangha, Kiranpal S; Singh, Rohit R; Kakroo, Mashhood; Jandarov, Roman; Harris, David M; Rubinstein, Jack; Becker, Richard C; McNally, Elizabeth M; Sadayappan, Sakthivel 2021. South Asian-Specific MYBPC3?25bp Deletion Carriers Display Hypercontraction and Impaired Diastolic Function Under Exercise Stress. Frontiers in cardiovascular medicine, 8 , 766339\n\nBecker, Richard C 2021. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series. Journal of thrombosis and thrombolysis, 52 3, 692-707\n\nBecker, Richard C 2021. Factor Xa inhibitors: critical considerations for clinical development and testing. Journal of thrombosis and thrombolysis, 52 2, 397-402\n\nBecker, Richard C 2021. COVID-19 and its sequelae: a platform for optimal patient care, discovery and training. Journal of thrombosis and thrombolysis, 51 3, 587-594\n\nBecker, Richard C; Bode, Christoph 2021. Medical publishing during the COVID-19 pandemic: then and now. Journal of thrombosis and thrombolysis, 51 4, 1101-1106\n\nBecker, Richard C; Gorog, Diana A 2021. International COVID-19 biomarkers colloquium. Journal of thrombosis and thrombolysis, 52 4, 983-984\n\nBecker, Richard C; Sexton, Travis; Smyth, Susan 2021. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. Journal of thrombosis and thrombolysis, 52 4, 1010-1019\n\nBlumer, Vanessa; Rivera, Manuel; Corbalán, Ramón; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Hellkamp, Anne S; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2021. Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF. American heart journal, 236 , 4-12\n\nCarnicelli, Anthony P; Hellkamp, Anne S; Mahaffey, Kenneth W; Singer, Daniel E; Breithardt, Günter; Halperin, Jonathan L; Hankey, Graeme J; Piccini, Jonathan P; Becker, Richard C; Nessel, Christopher C; Berkowitz, Scott D; Fox, Keith A A; Califf, Robert M; Patel, Manesh R 2021. Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial. Journal of the American Heart Association, 10 19, e022485\n\nGorog, Diana A; Becker, Richard C 2021. Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement. Journal of thrombosis and thrombolysis, 51 1, 1-11\n\nHamdani, Gilad; Mitsnefes, Mark M; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen; Falkner, Bonita E; Ferguson, Michael; Hooper, Stephen R; Hanevold, Coral D; Ingelfinger, Julie R; Lande, Marc; Martin, Lisa J; Meyers, Kevin E; Rosner, Bernard; Samuels, Joshua; Urbina, Elaine M 2021. Pediatric and Adult Ambulatory Blood Pressure Thresholds and Blood Pressure Load as Predictors of Left Ventricular Hypertrophy in Adolescents. Hypertension (Dallas, Tex. : 1979), 78 1, 30-37\n\nKoh, Cho Yeow; Shih, Norrapat; Yip, Christina Y C; Li, Aaron Wei Liang; Chen, Weiming; Amran, Fathiah S; Leong, Esther Jia En; Iyer, Janaki Krishnamoorthy; Croft, Grace; Mazlan, Muhammad Ibrahim Bin; Chee, Yen-Lin; Yap, Eng-Soo; Monroe, Dougald M; Hoffman, Maureane; Becker, Richard C; de Kleijn, Dominique P V; Verma, Vaishali; Gupta, Amita; Chaudhary, Vijay K; Richards, A Mark; Kini, R Manjunatha; Chan, Mark Y 2021. Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Nature communications, 12 1, 6912\n\nLam, Carolyn S P; Giczewska, Anna; Sliwa, Karen; Edelmann, Frank; Refsgaard, Jens; Bocchi, Edimar; Ezekowitz, Justin A; Hernandez, Adrian F; O'Connor, Christopher M; Roessig, Lothar; Patel, Mahesh J; Pieske, Burkert; Anstrom, Kevin J; Armstrong, Paul W 2021. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA cardiology, 6 6, 706-712\n\nLu, Haocheng; Du, Wa; Ren, Lu; Hamblin, Milton H; Becker, Richard C; Chen, Y Eugene; Fan, Yanbo 2021. Vascular Smooth Muscle Cells in Aortic Aneurysm: From Genetics to Mechanisms. Journal of the American Heart Association, 10 24, e023601\n\nMartin, Jay F; Kalcic, Margaret M; Aloysius, Noel; Apostel, Anna M; Brooker, Michael R; Evenson, Grey; Kast, Jeffrey B; Kujawa, Haley; Murumkar, Asmita; Becker, Richard; Boles, Chelsie; Confesor, Remegio; Dagnew, Awoke; Guo, Tian; Long, Colleen M; Muenich, Rebecca L; Scavia, Donald; Redder, Todd; Robertson, Dale M; Wang, Yu-Chen 2021. Evaluating management options to reduce Lake Erie algal blooms using an ensemble of watershed models. Journal of environmental management, 280 , 111710\n\nMilstone, Leonard M; Jackson, Craig; Becker, Richard C; Camire, Rodney; Knabb, Robert; Mann, Kenneth; Ruf, Wolfram; Wexler, Ruth R; Wood, Jeremy 2021. Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyond. Journal of thrombosis and thrombolysis, 52 2, 408-413\n\nSamman, Karla N; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y; Lopes, Renato D; Neely, Megan Lee; Wang, Tracy Y; Newby, L Kristin; Becker, Richard C; Lordkipanidzé, Marie; Ruiz, Matthieu; Hussin, Julie G; Jolicœur, E Marc 2021. Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel. Cell reports. Medicine, 2 6, 100299\n\nSantillan, Mark K; Becker, Richard C; Calhoun, David A; Cowley, Allen W; Flynn, Joseph T; Grobe, Justin L; Kotchen, Theodore A; Lackland, Daniel T; Leslie, Kimberly K; Liang, Mingyu; Mattson, David L; Meyers, Kevin E; Mitsnefes, Mark M; Muntner, Paul M; Pierce, Gary L; Pollock, Jennifer S; Sigmund, Curt D; Thomas, Stephen J; Urbina, Elaine M; Kidambi, Srividya 2021. Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience. Hypertension (Dallas, Tex. : 1979), 77 6, 1857-1866\n\nUgowe, Francis E; Hellkamp, Anne S; Wang, Allen; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P 2021. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Heart rhythm O2, 2 3, 215-222\n\nAli, Mahboob; Becker, Richard C 2020. Bridging Anticoagulation with Mechanical Heart Valves: Current Guidelines and Clinical Decisions. Current cardiology reports, 22 11, 130\n\nArif, Mohammed; Nabavizadeh, Pooneh; Song, Taejeong; Desai, Darshini; Singh, Rohit; Bazrafshan, Sholeh; Kumar, Mohit; Wang, Yigang; Gilbert, Richard J; Dhandapany, Perundurai S; Becker, Richard C; Kranias, Evangelia G; Sadayappan, Sakthivel 2020. Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3?25bp variant. Biophysical reviews, 12 4, 1065-1084\n\nArmstrong, Paul W; Pieske, Burkert; Anstrom, Kevin J; Ezekowitz, Justin; Hernandez, Adrian F; Butler, Javed; Lam, Carolyn S P; Ponikowski, Piotr; Voors, Adriaan A; Jia, Gang; McNulty, Steven E; Patel, Mahesh J; Roessig, Lothar; Koglin, Joerg; O'Connor, Christopher M 2020. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. The New England journal of medicine, 382 20, 1883-1893\n\nBeames, Tyler; Moreau, Marjory; Roberts, L Avery; Mansouri, Kamel; Haider, Saad; Smeltz, Marci; Nicolas, Chantel I; Doheny, Daniel; Phillips, Martin B; Yoon, Miyoung; Becker, Richard A; McMullen, Patrick D; Andersen, Melvin E; Clewell, Rebecca A; Hartman, Jessica K 2020. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Toxicology and applied pharmacology, 387 , 114774\n\nBecker, Kristian C; Kwee, Lydia Coulter; Neely, Megan L; Grass, Elizabeth; Jakubowski, Joseph A; Fox, Keith A A; White, Harvey D; Gregory, Simon G; Gurbel, Paul A; Carvalho, Leonardo de Pinto; Becker, Richard C; Magnus Ohman, E; Roe, Matthew T; Shah, Svati H; Chan, Mark Y 2020. Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements. Scientific reports, 10 1, 6169\n\nBecker, Richard C 2020. Anticipating the long-term cardiovascular effects of COVID-19. Journal of thrombosis and thrombolysis, 50 3, 512-524\n\nBecker, Richard C 2020. COVID-19-associated vasculitis and vasculopathy. Journal of thrombosis and thrombolysis, 50 3, 499-511\n\nBecker, Richard C 2020. COVID-19 update: Covid-19-associated coagulopathy. Journal of thrombosis and thrombolysis, 50 1, 54-67\n\nBecker, Richard C 2020. Covid-19 treatment update: follow the scientific evidence. Journal of thrombosis and thrombolysis, 50 1, 43-53\n\nBecker, Richard C 2020. Toward understanding the 2019 Coronavirus and its impact on the heart. Journal of thrombosis and thrombolysis, 50 1, 33-42\n\nBecker, Richard C 2020. Elite Reviewers 2019. Journal of thrombosis and thrombolysis, 49 4, 685-686\n\nBecker, Richard C; Owens, A Phillip; Sadayappan, Sakthivel 2020. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. Journal of thrombosis and thrombolysis, 49 2, 177-183\n\nBecker, Richard C; Phillip Owens, A; Sadayappan, Sakthivel 2020. The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy. Thrombosis research, 192 , 78-87\n\nBecker, Richard C; Sadayappan, Sakthivel 2020. Designing Human In Vitro Models for Drug Development. Journal of the American College of Cardiology, 75 6, 587-589\n\nEllison, Corie A; Api, Anne Marie; Becker, Richard A; Efremenko, Alina Y; Gadhia, Sanket; Hack, C Eric; Hewitt, Nicola J; Varcin, Mustafa; Schepky, Andreas 2020. Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future. Frontiers in toxicology, 2 , 621541\n\nGoodman, Julie E; Mayfield, David B; Becker, Richard A; Hartigan, Suzanne B; Erraguntla, Neeraja K 2020. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program. Regulatory toxicology and pharmacology : RTP, 113 , 104639\n\nGregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; Åkerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbäck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pål; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente 2020. Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 9 17, e016360\n\nJawitz, Oliver K; Wang, Tracy Y; Lopes, Renato D; Chavez, Alma; Boyer, Brittanny; Kim, Hwasoon; Anstrom, Kevin J; Becker, Richard C; Blackstone, Eugene; Ruel, Marc; Thourani, Vinod H; Puskas, John D; Gerdisch, Marc W; Johnston, Douglas; Capps, Scott; Alexander, John H; Svensson, Lars G 2020. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. American heart journal, 227 , 91-99\n\nKontny, Frederic; Andersen, Thomas; Ueland, Thor; Åkerblom, Axel; Lakic, Tatevik G; Michelsen, Annika E; Aukrust, Pål; Bertilsson, Maria; Becker, Richard C; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Wallentin, Lars 2020. Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial. European heart journal. Acute cardiovascular care, 9 4, 313-322\n\nKujawa, Haley; Kalcic, Margaret; Martin, Jay; Aloysius, Noel; Apostel, Anna; Kast, Jeffrey; Murumkar, Asmita; Evenson, Grey; Becker, Richard; Boles, Chelsie; Confesor, Remegio; Dagnew, Awoke; Guo, Tian; Logsdon Muenich, Rebecca; Redder, Todd; Scavia, Donald; Wang, Yu-Chen 2020. The hydrologic model as a source of nutrient loading uncertainty in a future climate. The Science of the total environment, 724 , 138004\n\nKumar, Mohit; Thangavel, Chellappagounder; Becker, Richard C; Sadayappan, Sakthivel 2020. Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity. Cancers, 13 1,\n\nMcNamara, James W; Schuckman, Maggie; Becker, Richard C; Sadayappan, Sakthivel 2020. A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy. Frontiers in physiology, 11 , 608473\n\nOlivotto, Iacopo; Oreziak, Artur; Barriales-Villa, Roberto; Abraham, Theodore P; Masri, Ahmad; Garcia-Pavia, Pablo; Saberi, Sara; Lakdawala, Neal K; Wheeler, Matthew T; Owens, Anjali; Kubanek, Milos; Wojakowski, Wojciech; Jensen, Morten K; Gimeno-Blanes, Juan; Afshar, Kia; Myers, Jonathan; Hegde, Sheila M; Solomon, Scott D; Sehnert, Amy J; Zhang, David; Li, Wanying; Bhattacharya, Mondira; Edelberg, Jay M; Waldman, Cynthia Burstein; Lester, Steven J; Wang, Andrew; Ho, Carolyn Y; Jacoby, Daniel 2020. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England), 396 10253, 759-769\n\nSauer, Ursula G; Barter, Robert A; Becker, Richard A; Benfenati, Emilio; Berggren, Elisabet; Hubesch, Bruno; Hollnagel, Heli M; Inawaka, Kunifumi; Keene, Athena M; Mayer, Philipp; Plotzke, Kathleen; Skoglund, Robert; Albert, Océane 2020. 21st Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights. Regulatory toxicology and pharmacology : RTP, 111 , 104583\n\nTran, Andrew H; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral D; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua A; Urbina, Elaine M 2020. Subclinical Systolic and Diastolic Dysfunction Is Evident in Youth With Elevated Blood Pressure. Hypertension (Dallas, Tex. : 1979), 75 6, 1551-1556\n\nUeland, Thor; Åkerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Becker, Richard C; Bertilsson, Maria; Budaj, Andrzej; Cornel, Jan H; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pål; Wallentin, Lars 2020. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Atherosclerosis, 293 , 35-41\n\nÅkerblom, Axel; James, Stefan K; Lakic, Tatevik G; Becker, Richard C; Cannon, Christopher P; Steg, Philippe G; Himmelmann, Anders; Katus, Hugo A; Storey, Robert F; Wallentin, Lars; Weaver, W Douglas; Siegbahn, Agneta 2019. Interleukin-18 in patients with acute coronary syndromes. Clinical cardiology, 42 12, 1202-1209\n\nÅkerblom, Axel; Wojdyla, Daniel M; Wallentin, Lars; James, Stefan K; de Souza Brito, Flávio; Steg, Philippe Gabriel; Cannon, Christopher P; Katus, Hugo A; Himmelmann, Anders; Storey, Robert F; Becker, Richard C; Lopes, Renato D 2019. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. American heart journal, 213 , 57-65\n\nÅkerblom, Axel; Wojdyla, Daniel; Steg, Philippe Gabriel; Wallentin, Lars; James, Stefan K; Budaj, Andrzej; Katus, Hugo A; Himmelmann, Anders; Huber, Kurt; Siegbahn, Agneta; Storey, Robert F; Becker, Richard C 2019. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Journal of thrombosis and thrombolysis, 48 4, 563-569\n\nAndersen, Melvin E; McMullen, Patrick D; Phillips, Martin B; Yoon, Miyoung; Pendse, Salil N; Clewell, Harvey J; Hartman, Jessica K; Moreau, Marjory; Becker, Richard A; Clewell, Rebecca A 2019. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs). ALTEX, 36 4, 523-534\n\nAndersen, Thomas; Ueland, Thor; Ghukasyan Lakic, Tatevik; Åkerblom, Axel; Bertilsson, Maria; Aukrust, Pål; Michelsen, Annika E; James, Stefan K; Becker, Richard C; Storey, Robert F; Wallentin, Lars; Siegbahn, Agneta; Kontny, Frederic 2019. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arteriosclerosis, thrombosis, and vascular biology, 39 11, 2402-2410\n\nArif, Mohammed; Sadayappan, Sakthivel; Becker, Richard C; Martin, Lisa J; Urbina, Elaine M 2019. Epigenetic modification: a regulatory mechanism in essential hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 42 8, 1099-1113\n\nBecker, Richard C 2019. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. The New England journal of medicine, 381 12, 1169-1170\n\nBecker, Richard C; Cotarlan, Vlad; Sadayappan, Sakthi 2019. The rapid proliferation of solicited content online journals: a quest to disseminate knowledge? Journal of thrombosis and thrombolysis, 47 3, 337-344\n\nChen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R; Melloni, Chiara 2019. Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. European heart journal. Quality of care & clinical outcomes, 5 2, 145-152\n\nGouin, Todd; Becker, Richard A; Collot, Anne-Gaelle; Davis, John W; Howard, Brett; Inawaka, Kunifumi; Lampi, Mark; Ramon, Blanca Serrano; Shi, Jay; Hopp, Philipp W 2019. Toward the Development and Application of an Environmental Risk Assessment Framework for Microplastic. Environmental toxicology and chemistry, 38 10, 2087-2100\n\nKessler, Thorsten; Wolf, Bernhard; Eriksson, Niclas; Kofink, Daniel; Mahmoodi, Bakhtawar K; Rai, Himanshu; Tragante, Vinicius; Åkerblom, Axel; Becker, Richard C; Bernlochner, Isabell; Bopp, Roman; James, Stefan; Katus, Hugo A; Mayer, Katharina; Munz, Matthias; Nordio, Francesco; O'Donoghue, Michelle L; Sager, Hendrik B; Sibbing, Dirk; Solakov, Linda; Storey, Robert F; Wobst, Jana; Asselbergs, Folkert W; Byrne, Robert A; Erdmann, Jeanette; Koenig, Wolfgang; Laugwitz, Karl-Ludwig; Ten Berg, Jurrien M; Wallentin, Lars; Kastrati, Adnan; Schunkert, Heribert 2019. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention. Cardiovascular research, 115 10, 1512-1518\n\nMehta, Radha; Athar, Muhammad; Girgis, Sameh; Hassan, Atif; Becker, Richard C 2019. Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians. Journal of thrombosis and thrombolysis, 48 1, 14-26\n\nNimjee, Shahid M; Dornbos, David; Pitoc, George A; Wheeler, Debra G; Layzer, Juliana M; Venetos, Nicholas; Huttinger, Allyson; Talentino, Spencer E; Musgrave, Nicholas J; Moody, Holly; Rempel, Rachel E; Jones, Cheyenne; Carlisle, Kendyl; Wilson, Jenna; Bratton, Camille; Joseph, Matthew E; Khan, Shoeb; Hoffman, Maureane R; Sommerville, Laura; Becker, Richard C; Zweier, Jay L; Sullenger, Bruce A 2019. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels. Molecular therapy : the journal of the American Society of Gene Therapy, 27 7, 1228-1241\n\nParker, William A E; Eriksson, Niclas; Becker, Richard C; Voora, Deepak; Åkerblom, Axel; Himmelmann, Anders; James, Stefan K; Wallentin, Lars; Storey, Robert F 2019. Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. Platelets, 30 5, 579-588\n\nTabish, Ali M; Arif, Mohammed; Song, Taejeong; Elbeck, Zaher; Becker, Richard C; Knöll, Ralph; Sadayappan, Sakthivel 2019. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. American journal of physiology. Heart and circulatory physiology, 317 1, H168-H180\n\nThomas, Mark R; James, Stefan K; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Cannon, Christopher P; Steg, Philippe Gabriel; Siegbahn, Agneta; Lakic, Tatevik; Storey, Robert F; Wallentin, Lars 2019. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. European heart journal. Acute cardiovascular care, , 2048872619878075\n\nThomas, Mark R; James, Stefan K; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Cannon, Christopher P; Steg, Philippe Gabriel; Siegbahn, Agneta; Lakic, Tatevik; Storey, Robert F; Wallentin, Lars 2019. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. European heart journal. Acute cardiovascular care, ,\n\nUeland, Thor; Åkerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Becker, Richard C; Bertilsson, Maria; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pål; Wallentin, Lars 2019. Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. Arteriosclerosis, thrombosis, and vascular biology, 39 2, 294-302\n\nUngar, Leo; Rodriguez, Fatima; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Guenter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P; Mahaffey, Kenneth W 2019. Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF. Cardiology and therapy, 8 2, 283-295\n\nUrbina, Elaine M; Mendizábal, Brenda; Becker, Richard C; Daniels, Steve R; Falkner, Bonita E; Hamdani, Gilad; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lanade, Marc; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2019. Association of Blood Pressure Level With Left Ventricular Mass in Adolescents. Hypertension (Dallas, Tex. : 1979), 74 3, 590-596\n\nAli, Mahboob; Girgis, Sameh; Hassan, Atif; Rudick, Steven; Becker, Richard C 2018. Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Coronary artery disease, 29 5, 429-437\n\nBarnett, Adam S; Cyr, Derek D; Goodman, Shaun G; Levitan, Bennett S; Yuan, Zhong; Hankey, Graeme J; Singer, Daniel E; Becker, Richard C; Breithardt, Günter; Berkowitz, Scott D; Halperin, Jonathan L; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Fox, Keith A A; Patel, Manesh R; Piccini, Jonathan P 2018. Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. International journal of cardiology, 257 , 78-83\n\nBecker, Richard C 2018. A legacy of words. Journal of thrombosis and thrombolysis, 45 2, 197-199\n\nBecker, Richard C; Sexton, Travis; Smyth, Susan S 2018. Translational Implications of Platelets as Vascular First Responders. Circulation research, 122 3, 506-522\n\nChen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2018. Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF. American heart journal, 200 , 102-109\n\nDeWald, Tracy A; Washam, Jeffrey B; Becker, Richard C 2018. Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications. Neurosurgery clinics of North America, 29 4, 503-515\n\nHamdani, Gilad; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen R; Falkner, Bonita; Hanevold, Coral D; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin E; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua A; Urbina, Elaine M 2018. Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents. Hypertension (Dallas, Tex. : 1979), 72 4, 955-961\n\nKochar, Ajar; Hellkamp, Anne S; Lokhnygina, Yuliya; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Piccini, Jonathan P; Patel, Manesh R 2018. Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial. Clinical cardiology, 41 1, 39-45\n\nLi, Emily; Howard, Martha A; Vining, Eugenia M; Becker, Richard D; Silbert, Jonathan; Lesser, Robert L 2018. Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: A systematic review. Orbit (Amsterdam, Netherlands), 37 4, 280-286\n\nMendizábal, Brenda; Urbina, Elaine M; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Hamdani, Gilad; Hanevold, Coral D; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua A; Flynn, Joseph T 2018. SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth). Hypertension (Dallas, Tex. : 1979), 72 3, 625-631\n\nMoore, Martha M; Schoeny, Rita S; Becker, Richard A; White, Kimberly; Pottenger, Lynn H 2018. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Critical reviews in toxicology, 48 4, 312-337\n\nOthman, Abdullah; Sultan, Mohamed; Becker, Richard; Alsefry, Saleh; Alharbi, Talal; Gebremichael, Esayas; Alharbi, Hassan; Abdelmohsen, Karem 2018. Use of Geophysical and Remote Sensing Data for Assessment of Aquifer Depletion and Related Land Deformation. Surveys in geophysics, 39 3, 543-566\n\nOuyang, Zutao; Qian, Song S; Becker, Richard; Chen, Jiquan 2018. The effects of nutrients on stream invertebrates: a regional estimation by generalized propensity score. Ecological processes, 7 1, 21\n\nPatlewicz, Grace; Wambaugh, John F; Felter, Susan P; Simon, Ted W; Becker, Richard A 2018. Utilizing Threshold of Toxicological Concern (TTC) with High Throughput Exposure Predictions (HTE) as a Risk-Based Prioritization Approach for thousands of chemicals. Computational toxicology (Amsterdam, Netherlands), 7 , 58-67\n\nQuinn, Gene R; Hellkamp, Anne S; Hankey, Graeme J; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fava, Maurizio; Fox, Keith A A; Halperin, Jonathan L; Mahaffey, Kenneth W; Nessel, Christopher C; Patel, Manesh R; Piccini, Jonathan P; Singer, Daniel E 2018. Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. Journal of the American Heart Association, 7 15, e008755\n\nScirica, Benjamin M; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W; Clare, Robert M; Schulte, Phillip J; Pieper, Karen S; Becker, Richard C; James, Stefan K; Storey, Robert F; Steg, Philippe Gabriel; Held, Claes; Himmelmann, Anders; Mahaffey, Kenneth W; Wallentin, Lars; Cannon, Christopher P 2018. Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis. American heart journal, 202 , 54-60\n\nStorey, Robert F; Ardissino, Diego; Vignali, Luigi; Cairns, Richard; Becker, Richard C; Cannon, Christopher P; Mahaffey, Kenneth W; Himmelmann, Anders; Katus, Hugo A; James, Stefan K; Wallentin, Lars 2018. Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study. Thrombosis and haemostasis, 118 2, 427-429\n\nUeland, Thor; Åkerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Aukrust, Pål; Becker, Richard C; Bertilsson, Maria; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Wallentin, Lars 2018. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 7 2,\n\nViswanathan, Shiv Kumar; Puckelwartz, Megan J; Mehta, Ashish; Ramachandra, Chrishan J A; Jagadeesan, Aravindakshan; Fritsche-Danielson, Regina; Bhat, Ratan V; Wong, Philip; Kandoi, Sangeetha; Schwanekamp, Jennifer A; Kuffel, Gina; Pesce, Lorenzo L; Zilliox, Michael J; Durai, U Nalla B; Verma, Rama Shanker; Molokie, Robert E; Suresh, Domodhar P; Khoury, Philip R; Thomas, Annie; Sanagala, Thriveni; Tang, Hak Chiaw; Becker, Richard C; Knöll, Ralph; Shim, Winston; McNally, Elizabeth M; Sadayappan, Sakthivel 2018. Association of Cardiomyopathy With MYBPC3 D389V and MYBPC3?25bpIntronic Deletion in South Asian Descendants. JAMA cardiology, 3 6, 481-488\n\nBalla, Somasekhara R; Cyr, Derek D; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2017. Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial). The American journal of cardiology, 119 12, 1989-1996\n\nBecker, Richard A; Dreier, David A; Manibusan, Mary K; Cox, Louis A Tony; Simon, Ted W; Bus, James S 2017. How well can carcinogenicity be predicted by high throughput \"characteristics of carcinogens\" mechanistic data? Regulatory toxicology and pharmacology : RTP, 90 , 185-196\n\nBecker, Richard C 2017. Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient? JACC. Basic to translational science, 2 2, 146-148\n\nBecker, Richard; Haight, Sean 2017. Glenohumeral Joint Sepsis after Joint Injection through a New Tattoo. Journal of radiology case reports, 11 11, 28-35\n\nChen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2017. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). The American journal of cardiology, 120 10, 1837-1840\n\nDucrocq, Gregory; Schulte, Phillip J; Budaj, Andrzej; Cornel, Jan H; Held, Claes; Himmelmann, Anders; Husted, Steen; Storey, Robert F; Cannon, Christopher P; Becker, Richard C; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Sorbets, Emmanuel; Wallentin, Lars; Steg, Philippe Gabriel 2017. Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes. American heart journal, 186 , 91-99\n\nFeigal, Jacob P; Boyle, Stephen H; Samad, Zainab; Velazquez, Eric J; Wilson, Jennifer L; Becker, Richard C; Williams, Redford B; Kuhn, Cynthia M; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Jiang, Wei 2017. Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemia. Journal of psychosomatic research, 93 , 14-18\n\nJiang, Rong; Babyak, Michael A; Brummett, Beverly H; Hauser, Elizabeth R; Shah, Svati H; Becker, Richard C; Siegler, Ilene C; Singh, Abanish; Haynes, Carol; Chryst-Ladd, Megan; Craig, Damian M; Williams, Redford B 2017. Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort. American heart journal, 190 , 40-45\n\nJohnson, David A; Lieberman, David; Inadomi, John M; Ladabaum, Uri; Becker, Richard C; Gross, Seth A; Hood, Kristin L; Kushins, Susan; Pochapin, Mark; Robertson, Douglas J 2017. Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 6, 883-891.e9\n\nLeef, George C; Hellkamp, Anne S; Patel, Manesh R; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Mahaffey, Kenneth W; Piccini, Jonathan P 2017. Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial. Journal of the American Heart Association, 6 6,\n\nLindholm, Daniel; Hagström, Emil; James, Stefan K; Becker, Richard C; Cannon, Christopher P; Himmelmann, Anders; Katus, Hugo A; Maurer, Gerald; López-Sendón, José Luis; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2017. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding. Journal of the American Heart Association, 6 4,\n\nLindholm, Daniel; James, Stefan K; Bertilsson, Maria; Becker, Richard C; Cannon, Christopher P; Giannitsis, Evangelos; Harrington, Robert A; Himmelmann, Anders; Kontny, Frederic; Siegbahn, Agneta; Steg, Philippe Gabriel; Storey, Robert F; Velders, Matthijs A; Weaver, W Douglas; Wallentin, Lars 2017. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome. Clinical chemistry, 63 2, 573-584\n\nLindner, Samuel M; Fordyce, Christopher B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Breithardt, Günter; Mahaffey, Kenneth W; Singer, Daniel E; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Fox, Keith A A; Patel, Manesh R 2017. Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. Circulation, 135 10, 1001-1003\n\nLowenstern, Angela; Storey, Robert F; Neely, Megan; Sun, Jie-Lena; Angiolillo, Dominick J; Cannon, Christopher P; Himmelmann, Anders; Huber, Kurt; James, Stefan K; Katus, Hugo A; Morais, Joao; Siegbahn, Agneta; Steg, Phillippe Gabriel; Wallentin, Lars; Becker, Richard C 2017. Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Journal of thrombosis and thrombolysis, 44 2, 145-153\n\nNimjee, Shahid M; White, Rebekah R; Becker, Richard C; Sullenger, Bruce A 2017. Aptamers as Therapeutics. Annual review of pharmacology and toxicology, 57 , 61-79\n\nPollack, Charles V; Davoudi, Farideh; Diercks, Deborah B; Becker, Richard C; James, Stefan K; Lim, Soo Teik; Schulte, Phillip J; Spinar, Jindrich; Steg, Philippe Gabriel; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Cannon, Christopher P 2017. Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial. Clinical cardiology, 40 6, 390-398\n\nStaudacher, Dawid L; Putz, Vera; Heger, Lukas; Reinöhl, Jochen; Hortmann, Marcus; Zelenkofske, Steven L; Becker, Richard C; Rusconi, Christopher P; Bode, Christoph; Ahrens, Ingo 2017. Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. European heart journal. Acute cardiovascular care, , 2048872617703065\n\nSun, Julia L; Boyle, Stephen H; Samad, Zainab; Babyak, Michael A; Wilson, Jennifer L; Kuhn, Cynthia; Becker, Richard C; Ortel, Thomas L; Williams, Redford B; Rogers, Joseph G; O'Connor, Christopher M; Velazquez, Eric J; Jiang, Wei 2017. Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. European journal of preventive cardiology, 24 6, 591-599\n\nSun, Yihong; Hu, Dayi; Stevens, Susanna; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2017. Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial. Thrombosis research, 156 , 184-190\n\nWasham, Jeffrey B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Breithardt, Günter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Singer, Daniel E; Patel, Manesh R 2017. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). The American journal of cardiology, 120 4, 588-594\n\nAbo-Salem, Elsayed; Becker, Richard C 2016. Reversal of novel oral anticoagulants. Current opinion in pharmacology, 27 , 86-91\n\nBjörquist, Anna; Di Buduo, Christian A; Femia, Eti A; Storey, Robert F; Becker, Richard C; Balduini, Alessandra; Nylander, Sven; Cattaneo, Marco 2016. Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes. Thrombosis and haemostasis, 116 6, 1079-1088\n\nBreithardt, Günter; Baumgartner, Helmut; Berkowitz, Scott D; Hellkamp, Anne S; Piccini, Jonathan P; Lokhnygina, Yuliya; Halperin, Jonathan L; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Mahaffey, Kenneth W; Califf, Robert M; Fox, Keith A A; Patel, Manesh R 2016. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Heart (British Cardiac Society), 102 13, 1036-43\n\nDeVore, Adam D; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Guenter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R; Piccini, Jonathan P 2016. Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 8, 1135-42\n\nFordyce, Christopher B; Hellkamp, Anne S; Lokhnygina, Yuliya; Lindner, Samuel M; Piccini, Jonathan P; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Fox, Keith A A; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R 2016. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Circulation, 134 1, 37-47\n\nJohansson, Åsa; Eriksson, Niclas; Lindholm, Daniel; Varenhorst, Christoph; James, Stefan; Syvänen, Ann-Christine; Axelsson, Tomas; Siegbahn, Agneta; Barratt, Bryan J; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Wallentin, Lars 2016. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. Human molecular genetics, 25 7, 1447-56\n\nKayse, Regina; Becker, Richard C 2016. The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Annals of translational medicine, 4 Suppl 1, S26\n\nKim, Joonseok; Becker, Richard C 2016. Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events. Journal of thrombosis and thrombolysis, ,\n\nMuntner, Paul; Becker, Richard C; Calhoun, David; Chen, Daian; Cowley, Allen W; Flynn, Joseph T; Grobe, Justin L; Kidambi, Srividya; Kotchen, Theodore A; Lackland, Daniel T; Leslie, Kimberly K; Li, Yingchuan; Liang, Mingyu; Lloyd, Augusta; Mattson, David L; Mendizabal, Brenda; Mitsnefes, Mark; Nair, Anand; Pierce, Gary L; Pollock, Jennifer S; Safford, Monika M; Santillan, Mark K; Sigmund, Curt D; Thomas, Stephen J; Urbina, Elaine M 2016. Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. Hypertension (Dallas, Tex. : 1979), 67 4, 674-80\n\nNimjee, Shahid M; Povsic, Thomas J; Sullenger, Bruce A; Becker, Richard C 2016. Translation and Clinical Development of Antithrombotic Aptamers. Nucleic acid therapeutics, 26 3, 147-55\n\nPiccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Günter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2016. Response by Piccini et al to Letters Regarding Article, \"Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation\". Circulation, 134 2, e7-8\n\nPokorney, Sean D; Piccini, Jonathan P; Stevens, Susanna R; Patel, Manesh R; Pieper, Karen S; Halperin, Jonathan L; Breithardt, Günter; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2016. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Journal of the American Heart Association, 5 3, e002197\n\nPovsic, Thomas J; Lawrence, Monica G; Lincoff, A Michael; Mehran, Roxana; Rusconi, Christopher P; Zelenkofske, Steven L; Huang, Zhen; Sailstad, Jeffrey; Armstrong, Paul W; Steg, P Gabriel; Bode, Christoph; Becker, Richard C; Alexander, John H; Adkinson, N Franklin; Levinson, Arnold I 2016. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. The Journal of allergy and clinical immunology, 138 6, 1712-1715\n\nRuff, Christian T; Ansell, Jack E; Becker, Richard C; Benjamin, Emelia J; Deicicchi, David J; Mark Estes, N A; Ezekowitz, Michael D; Fanikos, John; Fareed, Jawed; Garcia, David; Giugliano, Robert P; Goldhaber, Samuel Z; Granger, Christopher; Healey, Jeff S; Hull, Russell; Hylek, Elaine M; Libby, Peter; Lopes, Renato D; Mahaffey, Kenneth W; Mega, Jessica; Piazza, Gregory; Sasahara, Arthur A; Sorond, Farzaneh A; Spyropoulos, Alex C; Walenga, Jeanine M; Weitz, Jeffrey I 2016. North American Thrombosis Forum, AF Action Initiative Consensus Document. The American journal of medicine, 129 5 Suppl, S1-S29\n\nShah, Rohan; Hellkamp, Anne; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Fox, Keith A A; Nessel, Christopher C; Mahaffey, Kenneth W; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2016. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. American heart journal, 179 , 77-86\n\nSherwood, Matthew W; Cyr, Derek D; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Washam, Jeffrey B; Breithardt, Günter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Singer, Daniel E; Piccini, Jonathan P; Nessel, Christopher C; Mahaffey, Kenneth W; Patel, Manesh R 2016. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. JACC. Cardiovascular interventions, 9 16, 1694-702\n\nShimada, Yuichi J; Bansilal, Sameer; Wiviott, Stephen D; Becker, Richard C; Harrington, Robert A; Himmelmann, Anders; Neely, Benjamin; Husted, Steen; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Steg, Ph Gabriel; Storey, Robert F; Wallentin, Lars; Cannon, Christopher P 2016. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American heart journal, 177 , 1-8\n\nVemulapalli, Sreekanth; Hellkamp, Anne S; Jones, W Schuyler; Piccini, Jonathan P; Mahaffey, Kenneth W; Becker, Richard C; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Breithardt, Günter; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2016. Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial. American heart journal, 178 , 74-84\n\nBansilal, Sameer; Bloomgarden, Zachary; Halperin, Jonathan L; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Becker, Richard C; Breithardt, Günter; Hacke, Werner; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Berkowitz, Scott D; Piccini, Jonathan P; Mahaffey, Kenneth W; Fox, Keith A A 2015. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial). American heart journal, 170 4, 675-682.e8\n\nBecker, Richard A; Ankley, Gerald T; Edwards, Stephen W; Kennedy, Sean W; Linkov, Igor; Meek, Bette; Sachana, Magdalini; Segner, Helmut; Van Der Burg, Bart; Villeneuve, Daniel L; Watanabe, Haruna; Barton-Maclaren, Tara S 2015. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. Regulatory toxicology and pharmacology : RTP, 72 3, 514-37\n\nBecker, Richard A; Friedman, Katie Paul; Simon, Ted W; Marty, M Sue; Patlewicz, Grace; Rowlands, J Craig 2015. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept. Regulatory toxicology and pharmacology : RTP, 71 3, 398-408\n\nBecker, Richard A; Patlewicz, Grace; Simon, Ted W; Rowlands, J Craig; Budinsky, Robert A 2015. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Regulatory toxicology and pharmacology : RTP, 73 1, 172-90\n\nBecker, Richard C 2015. The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotes. Journal of thrombosis and thrombolysis, ,\n\nBecker, Richard C 2015. Measurement tools and antidotes for non-vitamin K oral anticoagulants. Journal of thrombosis and thrombolysis, ,\n\nBecker, Richard C; Helmy, Tarek 2015. Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? Not all patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. Circulation, 131 22, 2010-9; discussion 2\n\nBorgert, Christopher J; Wise, Kimberly; Becker, Richard A 2015. Modernizing problem formulation for risk assessment necessitates articulation of mode of action. Regulatory toxicology and pharmacology : RTP, 72 3, 538-51\n\nDouketis, James D; Spyropoulos, Alex C; Kaatz, Scott; Becker, Richard C; Caprini, Joseph A; Dunn, Andrew S; Garcia, David A; Jacobson, Alan; Jaffer, Amir K; Kong, David F; Schulman, Sam; Turpie, Alexander G G; Hasselblad, Vic; Ortel, Thomas L 2015. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. The New England journal of medicine, 373 9, 823-33\n\nDucrocq, Gregory; Schulte, Phillip J; Becker, Richard C; Cannon, Christopher P; Harrington, Robert A; Held, Claes; Himmelmann, Anders; Lassila, Riitta; Storey, Robert F; Sorbets, Emmanuel; Wallentin, Lars; Steg, Philippe Gabriel 2015. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 11 8, 737-45\n\nGanjehei, Leila; Becker, Richard C 2015. Aspirin dosing in cardiovascular disease prevention and management: an update. Journal of thrombosis and thrombolysis, 40 4, 499-511\n\nHagström, Emil; James, Stefan K; Bertilsson, Maria; Becker, Richard C; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2015. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. European heart journal, ,\n\nJiang, Wei; Boyle, Stephen H; Ortel, Thomas L; Samad, Zainab; Velazquez, Eric J; Harrison, Robert W; Wilson, Jennifer; Kuhn, Cynthia; Williams, Redford B; O'Connor, Christopher M; Becker, Richard C 2015. Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. American heart journal, 169 4, 496-507.e1\n\nJohansson, Åsa; Eriksson, Niclas; Becker, Richard C; Storey, Robert F; Himmelmann, Anders; Hagström, Emil; Varenhorst, Christoph; Axelsson, Tomas; Barratt, Bryan J; James, Stefan K; Katus, Hugo A; Steg, Philippe Gabriel; Syvänen, Ann-Christine; Wallentin, Lars; Siegbahn, Agneta 2015. NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO). Circulation. Cardiovascular genetics, 8 3, 498-506\n\nKang, Hyun-Jae; Clare, Robert M; Gao, Runlin; Held, Claes; Himmelmann, Anders; James, Stefan K; Lim, Soo Teik; Santoso, Anwar; Yu, Cheuk-Man; Wallentin, Lars; Becker, Richard C 2015. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American heart journal, 169 6, 899-905.e1\n\nKrishnamoorthy, Arun; Sherwood, Matthew W; Lopes, Renato D; Becker, Richard C 2015. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. American heart journal, 169 3, 315-22\n\nLincoff, A Michael; Mehran, Roxana; Povsic, Thomas J; Zelenkofske, Steven L; Huang, Zhen; Armstrong, Paul W; Steg, P Gabriel; Bode, Christoph; Cohen, Mauricio G; Buller, Christopher; Laanmets, Peep; Valgimigli, Marco; Marandi, Toomas; Fridrich, Viliam; Cantor, Warren J; Merkely, Bela; Lopez-Sendon, Jose; Cornel, Jan H; Kasprzak, Jaroslaw D; Aschermann, Michael; Guetta, Victor; Morais, Joao; Sinnaeve, Peter R; Huber, Kurt; Stables, Rod; Sellers, Mary Ann; Borgman, Marilyn; Glenn, Lauren; Levinson, Arnold I; Lopes, Renato D; Hasselblad, Vic; Becker, Richard C; Alexander, John H 2015. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial. Lancet (London, England), ,\n\nMahaffy, P R; Webster, C R; Stern, J C; Brunner, A E; Atreya, S K; Conrad, P G; Domagal-Goldman, S; Eigenbrode, J L; Flesch, G J; Christensen, L E; Franz, H B; Freissinet, C; Glavin, D P; Grotzinger, J P; Jones, J H; Leshin, L A; Malespin, C; McAdam, A C; Ming, D W; Navarro-Gonzalez, R; Niles, P B; Owen, T; Pavlov, A A; Steele, A; Trainer, M G; Williford, K H; Wray, J J 2015. Mars atmosphere. The imprint of atmospheric evolution in the D/H of Hesperian clay minerals on Mars. Science (New York, N.Y.), 347 6220, 412-4\n\nPatlewicz, Grace; Simon, Ted W; Rowlands, J Craig; Budinsky, Robert A; Becker, Richard A 2015. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regulatory toxicology and pharmacology : RTP, 71 3, 463-77\n\nPiccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Günter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2015. Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation. Circulation, ,\n\nPlunkett, Laura M; Kaplan, A Michael; Becker, Richard A 2015. Challenges in using the ToxRefDB as a resource for toxicity prediction modeling. Regulatory toxicology and pharmacology : RTP, 72 3, 610-4\n\nSherwood, Matthew W; Nessel, Christopher C; Hellkamp, Anne S; Mahaffey, Kenneth W; Piccini, Jonathan P; Suh, Eun-Young; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Fox, Keith A A; Patel, Manesh R 2015. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. Journal of the American College of Cardiology, 66 21, 2271-81\n\nSinger, Daniel E; Hellkamp, Anne S; Yuan, Zhong; Lokhnygina, Yuliya; Patel, Manesh R; Piccini, Jonathan P; Hankey, Graeme J; Breithardt, Günter; Halperin, Jonathan L; Becker, Richard C; Hacke, Werner; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2015. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. Journal of the American Heart Association, 4 3, e001349\n\nSteinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Günter; Hankey, Graeme J; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hacke, Werner; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2015. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. European heart journal, 36 5, 288-96\n\nVarenhorst, Christoph; Eriksson, Niclas; Johansson, Åsa; Barratt, Bryan J; Hagström, Emil; Åkerblom, Axel; Syvänen, Ann-Christine; Becker, Richard C; James, Stefan K; Katus, Hugo A; Husted, Steen; Steg, Ph Gabriel; Siegbahn, Agneta; Voora, Deepak; Teng, Renli; Storey, Robert F; Wallentin, Lars 2015. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. European heart journal, 36 29, 1901-12\n\nVelders, Matthijs A; Wallentin, Lars; Becker, Richard C; van Boven, Adrianus J; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Lindholm, Daniel; Morais, Joao; Siegbahn, Agneta; Storey, Robert F; Wernroth, Lisa; James, Stefan K 2015. Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial. American heart journal, 169 6, 879-889.e7\n\nWebster, Christopher R; Mahaffy, Paul R; Atreya, Sushil K; Flesch, Gregory J; Mischna, Michael A; Meslin, Pierre-Yves; Farley, Kenneth A; Conrad, Pamela G; Christensen, Lance E; Pavlov, Alexander A; Martín-Torres, Javier; Zorzano, María-Paz; McConnochie, Timothy H; Owen, Tobias; Eigenbrode, Jennifer L; Glavin, Daniel P; Steele, Andrew; Malespin, Charles A; Archer, P Douglas; Sutter, Brad; Coll, Patrice; Freissinet, Caroline; McKay, Christopher P; Moores, John E; Schwenzer, Susanne P; Bridges, John C; Navarro-Gonzalez, Rafael; Gellert, Ralf; Lemmon, Mark T 2015. Mars atmosphere. Mars methane detection and variability at Gale crater. Science (New York, N.Y.), 347 6220, 415-7\n\nAbo-Salem, Elsayed; Becker, Richard 2014. Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians. Journal of thrombosis and thrombolysis, 37 3, 372-9\n\nAhmad, Tariq; Becker, Richard C 2014. The unmet need for philanthropic funding of early career cardiovascular investigators. Journal of thrombosis and thrombolysis, 37 4, 527-31\n\nAkerblom, Axel; Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta; Barratt, Bryan J; Becker, Richard C; Budaj, Andrzej; Himmelmann, Anders; Husted, Steen; Storey, Robert F; Johansson, Asa; James, Stefan K 2014. Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study. American heart journal, 168 1, 96-102.e2\n\nBecker, Richard C 2014. Editor's page. Journal of thrombosis and thrombolysis, 37 2, 216\n\nBreithardt, Günter; Baumgartner, Helmut; Berkowitz, Scott D; Hellkamp, Anne S; Piccini, Jonathan P; Stevens, Susanna R; Lokhnygina, Yuliya; Patel, Manesh R; Halperin, Jonathan L; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. European heart journal, 35 47, 3377-85\n\nDaly, Patrick L; Becker, Richard C 2014. Pharmacogenetics of antiplatelet therapy. Current atherosclerosis reports, 16 5, 411\n\nGoodman, Shaun G; Wojdyla, Daniel M; Piccini, Jonathan P; White, Harvey D; Paolini, John F; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Patel, Manesh R; Sherwood, Matthew W; Becker, Richard C; Halperin, Jonathan L; Hacke, Werner; Singer, Daniel E; Hankey, Graeme J; Breithardt, Gunter; Fox, Keith A A; Califf, Robert M 2014. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). Journal of the American College of Cardiology, 63 9, 891-900\n\nHalperin, Jonathan L; Hankey, Graeme J; Wojdyla, Daniel M; Piccini, Jonathan P; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Günter; Singer, Daniel E; Becker, Richard C; Hacke, Werner; Paolini, John F; Nessel, Christopher C; Mahaffey, Kenneth W; Califf, Robert M; Fox, Keith A A 2014. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation, 130 2, 138-46\n\nHankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Günter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke; a journal of cerebral circulation, 45 5, 1304-12\n\nHusted, Steen; James, Stefan K; Bach, Richard G; Becker, Richard C; Budaj, Andrzej; Heras, Magda; Himmelmann, Anders; Horrow, Jay; Katus, Hugo A; Lassila, Riita; Morais, Joao; Nicolau, José C; Steg, Ph Gabriel; Storey, Robert F; Wojdyla, Daniel; Wallentin, Lars 2014. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, 35 23, 1541-50\n\nMahaffey, Kenneth W; Held, Claes; Wojdyla, Daniel M; James, Stefan K; Katus, Hugo A; Husted, Steen; Steg, Philippe Gabriel; Cannon, Christopher P; Becker, Richard C; Storey, Robert F; Khurmi, Nardev S; Nicolau, José C; Yu, Cheuk-Man; Ardissino, Diego; Budaj, Andrzej; Morais, Joao; Montgomery, Debra; Himmelmann, Anders; Harrington, Robert A; Wallentin, Lars 2014. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American College of Cardiology, 63 15, 1493-9\n\nPatel, Manesh R; Becker, Richard C; Wojdyla, Daniel M; Emanuelsson, Hakan; Hiatt, William R; Horrow, Jay; Husted, Steen; Mahaffey, Kenneth W; Steg, P Gabriel; Storey, Robert F; Wallentin, Lars; James, Stefan K 2014. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. European journal of preventive cardiology, ,\n\nPatlewicz, Grace; Ball, Nicholas; Becker, Richard A; Booth, Ewan D; Cronin, Mark T D; Kroese, Dinant; Steup, David; van Ravenzwaay, Ben; Hartung, Thomas 2014. Read-across approaches--misconceptions, promises and challenges ahead. ALTEX, 31 4, 387-96\n\nPiccini, Jonathan P; Garg, Jyotsna; Patel, Manesh R; Lokhnygina, Yuliya; Goodman, Shaun G; Becker, Richard C; Berkowitz, Scott D; Breithardt, Günter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Nessel, Christopher C; Mahaffey, Kenneth W; Singer, Daniel E; Califf, Robert M; Fox, Keith A A 2014. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. European heart journal, 35 28, 1873-80\n\nPiccini, Jonathan P; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Harrell, Frank E; Singer, Daniel E; Becker, Richard C; Breithardt, Günter; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. Journal of the American Heart Association, 3 2, e000521\n\nPovsic, Thomas J; Vavalle, John P; Alexander, John H; Aberle, Laura H; Zelenkofske, Steven L; Becker, Richard C; Buller, Christopher E; Cohen, Mauricio G; Cornel, Jan H; Kasprzak, Jaroslaw D; Montalescot, Gilles; Fail, Peter S; Sarembock, Ian J; Mehran, Roxana 2014. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, ,\n\nSamad, Zainab; Boyle, Stephen; Ersboll, Mads; Vora, Amit N; Zhang, Ye; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Velazquez, Eric J; Jiang, Wei 2014. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. Journal of the American College of Cardiology, 64 16, 1669-78\n\nSchlaudecker, Jeffrey; Becker, Richard 2014. Inflammatory response and thrombosis in older individuals. Seminars in thrombosis and hemostasis, 40 6, 669-74\n\nSherwood, Matthew W; Douketis, James D; Patel, Manesh R; Piccini, Jonathan P; Hellkamp, Anne S; Lokhnygina, Yuliya; Spyropoulos, Alex C; Hankey, Graeme J; Singer, Daniel E; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Becker, Richard C 2014. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation, 129 18, 1850-9\n\nSmiley, Dia A; Becker, Richard C 2014. Factor IXa as a target for anticoagulation in thrombotic disorders and conditions. Drug discovery today, ,\n\nSteinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Halperin, Jonathan L; Breithardt, Günter; Passman, Rod; Hankey, Graeme J; Patel, Manesh R; Becker, Richard C; Singer, Daniel E; Hacke, Werner; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2014. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial. Heart rhythm : the official journal of the Heart Rhythm Society, 11 6, 925-32\n\nSteinhubl, Steven R; Eikelboom, John W; Hylek, Elaine M; Dauerman, Harold L; Smyth, Susan S; Becker, Richard C 2014. Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. Journal of thrombosis and thrombolysis, 37 3, 362-71\n\nStorey, Robert F; Kotha, Jayaprakash; Smyth, Susan S; Moliterno, David J; Rorick, Tyrus L; Moccetti, Tiziano; Valgimigli, Marco; Dery, Jean Pierre; Cornel, Jan H; Thomas, Gregory S; Huber, Kurt; Harrington, Robert A; Hord, Edward; Judge, Heather M; Chen, Edmond; Strony, John; Mahaffey, Kenneth W; Tricoci, Pierluigi; Becker, Richard C; Jennings, Lisa K 2014. Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thrombosis and haemostasis, 111 5, 883-91\n\nVoora, Deepak; Becker, Richard C 2014. A freeze on tailored antiplatelet therapy? Circulation, 129 21, 2088-90\n\nWallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo A; Mahaffey, Kenneth M; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. No misrepresentation of vital status follow-up in PLATO: Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: Challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014. International journal of cardiology, ,\n\nWallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo S; Mahaffey, Kenneth W; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology, 170 3, e59-62\n\nWallentin, Lars; Lindholm, Daniel; Siegbahn, Agneta; Wernroth, Lisa; Becker, Richard C; Cannon, Christopher P; Cornel, Jan H; Himmelmann, Anders; Giannitsis, Evangelos; Harrington, Robert A; Held, Claes; Husted, Steen; Katus, Hugo A; Mahaffey, Kenneth W; Steg, Ph Gabriel; Storey, Robert F; James, Stefan K 2014. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation, 129 3, 293-303\n\nWelsby, Ian J; Phillips-Bute, Barbara; Mathew, Joseph P; Newman, Mark F; Becker, Richard; Rao, Sunil; Milano, Carmelo A; Stafford-Smith, Mark 2014. ABO blood group influences transfusion and survival after cardiac surgery. Journal of thrombosis and thrombolysis, ,\n\nWisler, James W; Becker, Richard C 2014. Antithrombotic therapy: new areas to understand efficacy and bleeding. Expert opinion on therapeutic targets, 18 12, 1427-34\n\nWong, Ka Sing Lawrence; Hu, Dai Yi; Oomman, Abraham; Tan, Ru-San; Patel, Manesh R; Singer, Daniel E; Breithardt, Günter; Mahaffey, Kenneth W; Becker, Richard C; Califf, Robert; Fox, Keith A A; Berkowitz, Scott D; Hacke, Werner; Hankey, Graeme J 2014. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Stroke; a journal of cerebral circulation, 45 6, 1739-47\n\nÅkerblom, Axel; Wallentin, Lars; Larsson, Anders; Siegbahn, Agneta; Becker, Richard C; Budaj, Andrzej; Himmelmann, Anders; Horrow, Jay; Husted, Steen; Storey, Robert F; Asenblad, Nils; James, Stefan K 2013. Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study. Clinical chemistry, 59 9, 1369-75\n\nBecker, Richard C 2013. A thought experiment in contemporary drug development: informed bench-to-bedside strategies. Journal of the American Heart Association, 2 1, e000031\n\nBerger, Jeffrey S; Becker, Richard C; Kuhn, Cynthia; Helms, Michael J; Ortel, Thomas L; Williams, Redford 2013. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thrombosis and haemostasis, 109 1, 85-92\n\nBernacki, Gwen M; Becker, Richard C 2013. Oral anticoagulants in older adults with atrial fibrillation. Journal of thrombosis and thrombolysis, ,\n\nBrummett, Beverly H; Babyak, Michael A; Jiang, Rong; Shah, Svati H; Becker, Richard C; Haynes, Carol; Chryst-Ladd, Megan; Craig, Damian M; Hauser, Elizabeth R; Siegler, Ilene C; Kuhn, Cynthia M; Singh, Abanish; Williams, Redford B 2013. A functional polymorphism in the 5HTR2C gene associated with stress responses also predicts incident cardiovascular events. PloS one, 8 12, e82781\n\nDewald, Tracy A; Becker, Richard C 2013. The pharmacology of novel oral anticoagulants. Journal of thrombosis and thrombolysis, ,\n\nJackson, Larry R; Becker, Richard C 2013. Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal. Journal of thrombosis and thrombolysis, ,\n\nJames, Stefan K; Storey, Robert F; Pieper, Karen S; Cannon, Christopher P; Becker, Richard C; Steg, Philippe Gabriel; Wallentin, Lars; Harrington, Robert A 2013. Response to letter regarding article, \"Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials\". Stroke; a journal of cerebral circulation, 44 8, e95-6\n\nKrishnan, Anandi; Vogler, Erwin A; Sullenger, Bruce A; Becker, Richard C 2013. The effect of surface contact activation and temperature on plasma coagulation with an RNA aptamer directed against factor IXa. Journal of thrombosis and thrombolysis, 35 1, 48-56\n\nMahaffey, Kenneth W; Wojdyla, Daniel; Hankey, Graeme J; White, Harvey D; Nessel, Christopher C; Piccini, Jonathan P; Patel, Manesh R; Berkowitz, Scott D; Becker, Richard C; Halperin, Jonathan L; Singer, Daniel E; Califf, Robert M; Fox, Keith A A; Breithardt, Günter; Hacke, Werner 2013. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. Annals of internal medicine, 158 12, 861-8\n\nMentz, Robert J; Becker, Richard C 2013. Funding opportunities for clinical investigators in the early stages of career development in cardiovascular research. Journal of thrombosis and thrombolysis, ,\n\nPatel, Manesh R; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Zhang, Zhongxin; Mohanty, Surya; Singer, Daniel E; Hacke, Werner; Breithardt, Günter; Halperin, Jonathan L; Hankey, Graeme J; Becker, Richard C; Nessel, Christopher C; Berkowitz, Scott D; Califf, Robert M; Fox, Keith A A; Mahaffey, Kenneth W 2013. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Journal of the American College of Cardiology, 61 6, 651-8\n\nPiccini, Jonathan P; Stevens, Susanna R; Chang, YuChiao; Singer, Daniel E; Lokhnygina, Yuliya; Go, Alan S; Patel, Manesh R; Mahaffey, Kenneth W; Halperin, Jonathan L; Breithardt, Günter; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Fox, Keith A A; Califf, Robert M 2013. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation, 127 2, 224-32\n\nPovsic, Thomas J; Vavalle, John P; Aberle, Laura H; Kasprzak, Jaroslaw D; Cohen, Mauricio G; Mehran, Roxana; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Rynkiewicz, Andrzej; Ring, Michael E; Zeymer, Uwe; Natarajan, Madhu; Delarche, Nicolas; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2013. A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial. European heart journal, 34 31, 2481-9\n\nRodés-Cabau, Josep; Dauerman, Harold L; Cohen, Mauricio G; Mehran, Roxana; Small, Eric M; Smyth, Susan S; Costa, Marco A; Mega, Jessica L; O'Donoghue, Michelle L; Ohman, E Magnus; Becker, Richard C 2013. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events. Journal of the American College of Cardiology, ,\n\nSinger, Daniel E; Hellkamp, Anne S; Piccini, Jonathan P; Mahaffey, Kenneth W; Lokhnygina, Yuliya; Pan, Guohua; Halperin, Jonathan L; Becker, Richard C; Breithardt, Günter; Hankey, Graeme J; Hacke, Werner; Nessel, Christopher C; Patel, Manesh R; Califf, Robert M; Fox, Keith A A 2013. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. Journal of the American Heart Association, 2 1, e000067\n\nVavalle, John P; Povsic, Thomas J; Aberle, Laura H; Zelenkofske, Steven L; Mehran, Roxana; Kasprzak, Jaroslaw D; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Becker, Richard C; Alexander, John H; Cohen, Mauricio G 2013. Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial. The Journal of invasive cardiology, 25 11, 593-9\n\nVoora, Deepak; Cyr, Derek; Lucas, Joseph; Chi, Jen-Tsan; Dungan, Jennifer; McCaffrey, Timothy A; Katz, Richard; Newby, L Kristin; Kraus, William E; Becker, Richard C; Ortel, Thomas L; Ginsburg, Geoffrey S 2013. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. Journal of the American College of Cardiology, 62 14, 1267-76\n\nWong, Michael H; Atreya, Sushil K; Mahaffy, Paul N; Franz, Heather B; Malespin, Charles; Trainer, Melissa G; Stern, Jennifer C; Conrad, Pamela G; Manning, Heidi L K; Pepin, Robert O; Becker, Richard H; McKay, Christopher P; Owen, Tobias C; Navarro-González, Rafael; Jones, John H; Jakosky, Bruce M; Steele, Andrew 2013. Isotopes of nitrogen on Mars: Atmospheric measurements by?Curiosity's mass spectrometer. Geophysical research letters, 40 23, 6033-6037\n\nXu, Weixian; Holmes, Dajuanicia N; Becker, Richard C; Roe, Matthew T; Peterson, Eric D; Wang, Tracy Y 2013. Comparison of long-term outcomes between older Asian and white patients with non-ST-segment elevation myocardial infarction: findings from CRUSADE-CMS database. American heart journal, 166 6, 1050-5\n\nAkerblom, Åxel; Wallentin, Lars; Siegbahn, Agneta; Becker, Richard C; Budaj, Andrzej; Buck, Kristen; Giannitsis, Evangelos; Horrow, Jay; Husted, Steen; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Åsenblad, Nils; James, Stefan K 2012. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. Clinical chemistry, 58 1, 190-9\n\nAngiolillo, Dominick J; Schneider, David J; Bhatt, Deepak L; French, William J; Price, Matthew J; Saucedo, Jorge F; Shaburishvili, Tamaz; Huber, Kurt; Prats, Jayne; Liu, Tiepu; Harrington, Robert A; Becker, Richard C 2012. Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. Journal of thrombosis and thrombolysis, 34 1, 44-55\n\nChan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thrombosis and haemostasis, 108 6, 1180-91\n\nChan, Mark Y; Tan, Karen; Tan, Huay-Cheem; Huan, Pei-Tee; Li, Bei; Phua, Qian-Hui; Lee, Hong-Kai; Lee, Chi-Hang; Low, Adrian; Becker, Richard C; Ong, Wen-Chong; Richards, Mark A; Salim, Agus; Tai, E-Shyong; Koay, Evelyn 2012. CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects. Pharmacogenomics, 13 5, 533-42\n\nHankey, Graeme J; Patel, Manesh R; Stevens, Susanna R; Becker, Richard C; Breithardt, Günter; Carolei, Antonio; Diener, Hans-Christoph; Donnan, Geoffrey A; Halperin, Jonathan L; Mahaffey, Kenneth W; Mas, Jean-Louis; Massaro, Ayrton; Norrving, Bo; Nessel, Christopher C; Paolini, John F; Roine, Risto O; Singer, Daniel E; Wong, Lawrence; Califf, Robert M; Fox, Keith A A; Hacke, Werner 2012. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet neurology, 11 4, 315-22\n\nHusted, Steen; James, Stefan; Becker, Richard C; Horrow, Jay; Katus, Hugo; Storey, Robert F; Cannon, Christopher P; Heras, Magda; Lopes, Renato D; Morais, Joao; Mahaffey, Kenneth W; Bach, Richard G; Wojdyla, Daniel; Wallentin, Lars 2012. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circulation. Cardiovascular quality and outcomes, 5 5, 680-8\n\nNimjee, Shahid M; Lohrmann, Jens D; Wang, Haichen; Snyder, David J; Cummings, Thomas J; Becker, Richard C; Oney, Sabah; Sullenger, Bruce A 2012. Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. Molecular therapy : the journal of the American Society of Gene Therapy, 20 2, 391-7\n\nRowley, Jesse W; Finn, Aloke V; French, Patricia A; Jennings, Lisa K; Bluestein, Danny; Gross, Peter L; Freedman, Jane E; Steinhubl, Steven R; Zimmerman, Guy A; Becker, Richard C; Dauerman, Harold L; Smyth, Susan S 2012. Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Circulation. Cardiovascular interventions, 5 2, 296-304\n\nWisler, James W; Becker, Richard C 2012. A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. Critical pathways in cardiology, 11 2, 55-61\n\nWisler, James W; Becker, Richard C 2012. Oral factor Xa inhibitors for the long-term management of ACS. Nature reviews. Cardiology, 9 7, 392-401\n\nWisler, James W; Washam, Jeffrey B; Becker, Richard C 2012. Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia. Journal of thrombosis and thrombolysis, 33 3, 287-95\n\nAhmad, Tariq; Voora, Deepak; Becker, Richard C 2011. The pharmacogenetics of antiplatelet agents: towards personalized therapy? Nature reviews. Cardiology, 8 10, 560-71\n\nBecker, Richard C 2011. Early-onset obesity and the unwanted promise of thrombosis. Journal of thrombosis and thrombolysis, 32 1, 125-8\n\nFaxon, David P; Eikelboom, John W; Berger, Peter B; Holmes, David R; Bhatt, Deepak L; Moliterno, David J; Becker, Richard C; Angiolillo, Dominick J 2011. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thrombosis and haemostasis, 106 4, 572-84\n\nFox, Keith A A; Piccini, Jonathan P; Wojdyla, Daniel; Becker, Richard C; Halperin, Jonathan L; Nessel, Christopher C; Paolini, John F; Hankey, Graeme J; Mahaffey, Kenneth W; Patel, Manesh R; Singer, Daniel E; Califf, Robert M 2011. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. European heart journal, 32 19, 2387-94\n\nHeld, Claes; Asenblad, Nils; Bassand, Jean Pierre; Becker, Richard C; Cannon, Christopher P; Claeys, Marc J; Harrington, Robert A; Horrow, Jay; Husted, Steen; James, Stefan K; Mahaffey, Kenneth W; Nicolau, José C; Scirica, Benjamin M; Storey, Robert F; Vintila, Marius; Ycas, Joseph; Wallentin, Lars 2011. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American College of Cardiology, 57 6, 672-84\n\nLopes, Renato D; Becker, Richard C; Alexander, John H; Armstrong, Paul W; Califf, Robert M; Chan, Mark Y; Crowther, Mark; Granger, Christopher B; Harrington, Robert A; Hylek, Elaine M; James, Stefan K; Jolicoeur, E Marc; Mahaffey, Kenneth W; Newby, L Kristin; Peterson, Eric D; Pieper, Karen S; Van de Werf, Frans; Wallentin, Lars; White, Harvey D; Carvalho, Antonio C; Giraldez, Roberto R; Guimaraes, Helio P; Nader, Helena B; Kalil, Renato A K; Bizzachi, Joyce M A; Lopes, Antonio C; Garcia, David A 2011. Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil. Journal of thrombosis and thrombolysis, 32 2, 242-66\n\nPovsic, Thomas J; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Cornel, Jan H; Kasprzak, Jaros?aw D; Montalescot, Gilles; Joseph, Diane; Wargin, William A; Rusconi, Christopher P; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2011. A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. American heart journal, 161 2, 261-268.e1-2\n\nPovsic, Thomas J; Wargin, William A; Alexander, John H; Krasnow, Joshua; Krolick, Merill; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Zelenkofske, Steven L; Rusconi, Christopher P; Becker, Richard C 2011. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. European heart journal, 32 19, 2412-9\n\nStorey, Robert F; Becker, Richard C; Harrington, Robert A; Husted, Steen; James, Stefan K; Cools, Frank; Steg, Philippe Gabriel; Khurmi, Nardev S; Emanuelsson, Håkan; Cooper, Anna; Cairns, Richard; Cannon, Christopher P; Wallentin, Lars 2011. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. European heart journal, 32 23, 2945-53\n\nStorey, Robert F; Becker, Richard C; Harrington, Robert A; Husted, Steen; James, Stefan K; Cools, Frank; Steg, Philippe Gabriel; Khurmi, Nardev S; Emanuelsson, Hakan; Lim, Soo Teik; Cannon, Christopher P; Katus, Hugo A; Wallentin, Lars 2011. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). The American journal of cardiology, 108 11, 1542-6\n\nWoodruff, Rebecca S; Sullenger, Bruce; Becker, Richard C 2011. The many faces of the contact pathway and their role in thrombosis. Journal of thrombosis and thrombolysis, 32 1, 9-20\n\nXu, Weixian; Wang, Tracy Y; Becker, Richard C 2011. Hematologic diseases: from within the heart. Revista española de cardiología (English ed.), 64 7, 606-13\n\nBecker, Richard C; Gurbel, Paul A 2010. Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies. Thrombosis and haemostasis, 103 3, 535-44\n\nBrummett, Beverly H; Boyle, Stephen H; Ortel, Thomas L; Becker, Richard C; Siegler, Ilene C; Williams, Redford B 2010. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosomatic medicine, 72 4, 333-9\n\nCannon, Christopher P; Harrington, Robert A; James, Stefan; Ardissino, Diego; Becker, Richard C; Emanuelsson, Håkan; Husted, Steen; Katus, Hugo; Keltai, Matyas; Khurmi, Nardev S; Kontny, Frederic; Lewis, Basil S; Steg, Philippe Gabriel; Storey, Robert F; Wojdyla, Daniel; Wallentin, Lars 2010. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet, 375 9711, 283-93\n\nChan, Mark Y; Becker, Richard C; Sim, Ling-Ling; Tan, Virlynn; Lee, Chi-Hang; Low, Adrian F H; Teo, Swee-Guan; Ng, Kheng-Siang; Tan, Huay-Cheem; Yeo, Tiong-Cheng 2010. Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. Annals of the Academy of Medicine, Singapore, 39 3, 179-84\n\nCohen, Mauricio G; Purdy, Drew A; Rossi, Joseph S; Grinfeld, Liliana R; Myles, Shelley K; Aberle, Laura H; Greenbaum, Adam B; Fry, Edward; Chan, M"
    }
}